Showing 19 of 19 recruiting trials for “dengue-fever”
Butantan-DV Vaccine in Elderly Populations (DEN-04-IB)
A Controlled Human Infection Model of Dengue
👨⚕️ Barnaby E Young, MB BChir, PhD, National Centre for Infectious Diseases (NCID)📍 1 site📅 Started Mar 2026View details ↗
A Study of Dengue Tetravalent Vaccine (TDV) in Adults (Age 45 to 60 and >60 to 79 Years)
RecruitingNCT07409857 ↗
International Registry of Dengue Infection in Congenital Bleeding Disorders (DengueCBDR)
To Assess the Efficacy of Carica Papaya Leaf Extract in Improving Platelet Counts Among Pediatric Patients With Dengue-associated Thrombocytopenia
RecruitingNCT07007585 ↗
Risk Factors for Hospitalization and Transfusion Criteria in Patients With Dengue Virus Infection
A Study of 2 Doses of Tetravalent Dengue Vaccine (TDV) in Infants and Toddlers
RecruitingNCT07040202 ↗
Immune Responses to Dengue and Sepsis
Impact of IIT-SIT on Dengue Clusters
👨⚕️ Lee Ching Ng Group Director (Environmental Health Institute), PhD, Environmental Health Institute📍 1 site📅 Started Mar 2025View details ↗
RecruitingNCT06843226 ↗
A Study in Children and Adolescents on the Effectiveness of Takeda's Licensed Dengue Vaccine TDV Against Hospitalization Due to Dengue Disease
Efficacy of Montelukast in Preventing Transaminase Elevation in Adult Dengue Patients
👨⚕️ Worapong Nasomsong, MD, Phramongkutklao College of Medicine and Hospital📍 1 site📅 Started Jan 2025View details ↗
RecruitingNCT06388785 ↗
A Study to Monitor the Adverse Events of QDENGA Vaccine in Participants in Malaysia
RecruitingNCT06599970 ↗
Improving Disease Prevention Strategies by Integrating Socio-spatial Characterization of Human Mobility
Zanamivir Treatment of Vascular Permeability in Dengue (ZAP-DENGUE)
A Study to Assess the Efficacy, Safety and Pharmacokinetics of EYU688 in Patients With Dengue Fever
RecruitingNCT04486638 ↗
Dengvaxia US Pregnancy Registry
RecruitingNCT04839757 ↗
Dengue Vaccine Strategy in Children Aged 9 to 17 Years in the French Caribbean
Phase 2 Safety and Immunogenicity Study of Rift Valley Fever Vaccine
RecruitingNCT02190266 ↗
Pathogenesis and Genetics of Disseminated or Refractory Coccidioidomycosis
👨⚕️ Steven M Holland, M.D., National Institute of Allergy and Infectious Diseases (NIAID)📍 1 site📅 Started Sep 2014View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →